CollPlant Biotechnologies Receives Nasdaq Delisting Warning for Low Bid Price
Summary
CollPlant Biotechnologies Ltd. received a notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day compliance period to avoid potential delisting.
Key Events
-
Nasdaq Delisting Notice Received
CollPlant Biotechnologies Ltd. received a written notice from Nasdaq on March 23, 2026, indicating non-compliance with Listing Rule 5550(a)(2) due to its ordinary shares trading below $1.00 for 30 consecutive business days.
-
180-Day Compliance Period Granted
The company has been granted a 180-calendar day period, until September 21, 2026, to regain compliance. To do so, the closing bid price must meet or exceed $1.00 per share for at least 10 consecutive business days.
-
Potential for Reverse Stock Split
If compliance is not met within the initial period, the company may be afforded a second 180-day period, requiring it to meet other listing standards and potentially effect a reverse share split to cure the deficiency.
-
Exacerbates Prior Going Concern Warning
This delisting notice compounds concerns raised by the company's prior disclosure of a 'Going Concern Warning' in its F-3 shelf registration filed on January 9, 2026, highlighting ongoing financial pressures.
Analysis
CollPlant Biotechnologies Ltd. has received a formal notification from Nasdaq regarding its non-compliance with the minimum $1.00 bid price requirement. This is a critical development, especially for a micro-cap company that previously disclosed a "Going Concern Warning" in its F-3 shelf registration on January 9, 2026. While the company has a 180-day compliance period, the notice highlights significant financial challenges and could severely impact investor confidence and the company's ability to raise capital. Potential actions, such as a reverse stock split, are often dilutive or can be perceived negatively by the market. Investors should monitor the company's progress in regaining compliance and its overall financial stability.
At the time of this filing, CLGN was trading at $0.69 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $10.2M. The 52-week trading range was $0.50 to $4.98. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.